Stocks · News reference

Novozymes H1 Adj. EPS $1.27 Beats $0.60 Estimate, Sales $2.608B Beat $1.250B Estimate

Aug 20, 2026, 9:42 AMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 20, 2026, 8:05 AMBenzinga Insights
Novozymes Reports H1 2026 Results: Full Earnings Call Transcript
On Thursday, Novozymes (OTC:NVZMY) discussed quarterly financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensive financial data and
Read original at benzinga
NVZMY